PCD pharma franchise

CEFIACT 50* DRY SYRUP

APPLICATION

Prime choice for switch therapy owing to its very good efficacy and safety profile

Cefixime is more efficacious than Arnoxicillin in treating H.influenzae otitis media and should be preferred when H.influenzae is the suspected etiologic agent

Cefixime is superior to Trimethorpim/sulpha-methoxazole in the treatment of suspected Shigellosis in cases high rate of resistant to TMP-SMX

Effective in

Pneumonia
Bronchitis
Typhoid Fever
Sinusitis
UTI
Otitis Media

Highly stable in the presence of beta-lactamase enzymes
Effective and safe oral antibiotic for the treatment of acute respiratory tract infections